Ledger.Open graph →
SEC Form D · filed August 18, 2023

Ikena Oncology, Inc

Offering
$42.6M
Sold
$42.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Maria D. Koehler · Boston, MADirectorRichard D. Wooster · Boston, MADirectorIain D. Dukes · Boston, MADirectorOwen Hughes · Cambridge, MADirectorOtello D. Stampacchia · Boston, MADirectorJean-Francois D. Formela · Boston, MADirectorMichelle Zhang · Boston, MAExecJotin Marango · Boston, MAExecJeffrey Ecsedy · Boston, MAExecSergio Santillana · Boston, MAExecOwen Hughes · Cambridge, MADirectorMark Manfredi · Boston, MAExec · DirectorDavid Bonita · Montreal, Quebec, CanadaDirectorMaria D. Koehler · Boston, MADirectorSergio Santillana · Boston, MAExecRichard D. Wooster · Boston, MADirectorMichelle Zhang · Boston, MAExecJotin Marango · Boston, MAExecJeffrey Ecsedy · Boston, MAExecIain D. Dukes · Boston, MADirectorOwen Hughes · Sudbury, MADirectorMark Manfredi · Boston, MAExec · DirectorOtello D. Stampacchia · Boston, MADirectorJean-Francois D. Formela · Boston, MADirectorDavid Bonita · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗